Cerus Press Releases 

Cerus Endovascular and Balt Enter Strategic Distribution Agreement for Innovative Neurovascular Devices to Treat a Range of Intracranial Aneurysms

4 August 2020

 

Cerus Endovascular Receives CE Mark Approval for its Contour 021 device

27 July 2020

Cerus Endovascular Receives CE Mark Approval for its

Contour 021

29 April 2020

View or download Press Release

Cerus Endovascular Receives CE Mark Approvals for its Neqstent Coil Assisted Flow Diverter Designed to Treat Intracranial Aneurysms

22 April 2020

View or download Press Release

Cerus Endovascular Successfully Completes Series B Financing and Receives U.S. FDA Approval for its First Microcatheter

21 February 2020

View or download Press Release

 

 

 

 

 

 

 

 

Cerus Endovascular Expands Intellectual Property Portfolio Brings Patent Portfolio

to Five Issued U.S. Patents and over 20+ Pending Patent Applications 

27 November 2018

Cerus Endovascular Enrolls First Patients in CERUS Study to Treat Intra-Cranial Aneurysms Using Contour Neurovascular System™ to Reduce the Risk of Rupture 

13 November, 2018

 

Cerus Endovascular Strengthens Board of Directors with Appointment of John T. Kilcoyne

18 September, 2018  

 

 

Cerus Endovascular Promotes Stephen Griffin, PhD, to President: 

Company On-Track to Achieve Key Clinical and Regulatory Milestones 

11 May, 2018 

Cerus Endovascular Provides Corporate Update:

Controlled commercial roll-out of the Contour Neurovascular System™ progressing, with 25 key sites confirmed Highly successful first-in-man implantation of the NEQSTENT™ Intra-Saccular Stent completed, with additional cases anticipated

7 September, 2017

 

 

Cerus Endovascular Receives CE Mark Approval for its 

Contour Neurovascular System™, Designed to Treat Intracranial Aneurysms

18 February 2020

View or download Press Release

View or download Press Release

View or download Press Release

View or download Press Release

View or download Press Release

View or download Press Release

Tel: +1 (510) 651 4000

Cerus Endovascular Inc. 47757 Fremont Boulevard, Fremont, CA 94538 USA

APM007-01.T  11th of September 2020

Cerus Endovascular is an ISO 13485:2016 certified company. © 2019 Cerus Endovascular Inc. All rights reserved.